Ticagrelor or Clopidogrel in Elderly Patients With Myocardial Infarction: When the Choice Makes the Difference

Circulation. 2020 Nov 3;142(18):1709-1712. doi: 10.1161/CIRCULATIONAHA.120.050845. Epub 2020 Sep 1.

Authors

Piera Capranzano¹, Dominick J Angiolillo²

Affiliations

¹ Division of Cardiology, Policlinico Hospital, University of Catania, Italy (P.C.).
² Division of Cardiology, University of Florida College of Medicine, Jacksonville (D.J.A.).

PMID: 32867509
DOI: 10.1161/CIRCULATIONAHA.120.050845

No abstract available

Keywords: Editorials; elderly; myocardial infarction; platelet aggregation inhibitors.

Publication types

Editorial
Comment

MeSH terms

Aged
Clopidogrel / adverse effects
Humans
Myocardial Infarction* / diagnosis
Myocardial Infarction* / drug therapy
Platelet Aggregation Inhibitors / adverse effects
Ticagrelor / adverse effects

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticagrelor